AmSurg launched an offer to exchange up to $1.1 billion aggregate principal amount of its 5.625 percent Senior Notes due 2022, which have been registered under the Securities Act of 1933, as amended for any or all which are not registered under the Act.
Here are five things to know:
1. Exchange notes are substantially identical to the private notes, except exchange notes are registered under the Securities Act of 1933.
2. Restrictions on transfer and registration rights, and related additional interest provisions, applicable to the private notes, will not apply to the exchange notes.
3. Private notes were originally sold in a private practice to qualified institutional buyers under Rule 144A and to persons outside the United States under Regulation S, which was completed in connection with AmSurg's acquisition of Sheridan Healthcare in July 2014.
4. The exchange offer expires at 5 p.m. on Feb. 18, 2015. AmSurg could extend the offer.
5. Private notes valid tenders can be made, and may be withdrawn any time before the exchange expires.